Friday, December 26, 2025
HomeTagsOncology

Oncology

Tempus Announces Expansion of Collaboration with AstraZeneca to Leverage Tempus Next to Support Guideline-directed Biomarker Testing in NSCLC

Tempus, a leader in artificial intelligence and precision medicine, announces an expansion of its collaboration with AstraZeneca, which leverages Tempus Next to arm physicians with...

Ryght Welcomes Dr. Chadi Nabhan as Chief Medical Officer and Head of Strategy

Ryght, a leading healthcare technology company, announced the appointment of physician and author, Chadi Nabhan, MD, MBA, as its new Chief Medical Officer and...

Owkin Unveils AI-Driven Oncology and Immunology Pipeline, In-Licenses Best-in-Class Asset OKN4395

Owkin, the first end-to-end TechBio unicorn that uses cutting-edge causal AI to unlock precision drug discovery, development and diagnostics, has unveiled an innovative drug...

Nona Biosciences Announces Global License and Option Agreement with AstraZeneca for Monoclonal Antibody to be Developed into Novel Tumor Targeted Therapies

Nona Biosciences, a global biotechnology company providing a total solution from "Idea to IND" (I to ITM), ranging from target validation and antibody discovery...

Siren Biotechnology and Catalent Enter Partnership for Manufacturing of AAV Gene Therapies for Cancer

Siren Biotechnology, pioneers of Universal AAV Immuno-Gene Therapy for Cancer, and Catalent Inc., the leader in enabling the development and supply of better treatments...
0FansLike
3,912FollowersFollow
0SubscribersSubscribe
spot_img

Hot Topics